Tortugas debuts with $106M and brain drugs from Hansoh, Eisai
BioPharma Dive
Led by former Sage Therapeutics executives Jeff Jonas and Al Robichaud, the company is starting out with a portfolio of neurological medicines in clinical testing.
pharminent
April 21, 2026 (Last updated: April 22, 2026)
BioPharma Dive
Led by former Sage Therapeutics executives Jeff Jonas and Al Robichaud, the company is starting out with a portfolio of neurological medicines in clinical testing.
